Related references
Note: Only part of the references are listed.Tigecycline Displays In Vivo Bactericidal Activity against Extended-Spectrum- β-Lactamase-Producing Enterobacteriaceae after 72-Hour Exposure Period
Pamela R. Tessier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae
Mahableshwar Albur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects
Rosemeri Maurici da Silva et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
Grace C. Lee et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2012)
In Vitro and In Vivo Synergistic Effects of Cryptdin 2 and Ampicillin against Salmonella
Praveen Rishi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay
Spyros Pournaras et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi
Stephen W. Barthold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
Maria E. Pachon-Ibanez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
Elizabeth B. Hirsch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
Rajesh V. Dudhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing
Vincent H. Tam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
Scott A. Weisenberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Leanne B. Gasink et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies
J. M. Entenza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece
Spyros Pournaras et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
In Vitro and In Vivo Evaluations of Oxacillin Efficiency against mecA-Positive Oxacillin-Susceptible Staphylococcus aureus
Alexandros Ikonomidis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin- resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models
Kerry L. LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase-producing Klebsiella pneumoniae epidemic clone
Javier Cobo et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model
Yoshitomo Morinaga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests
Athanassios Tsakris et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus
Sharath S. Hegde et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis
Andreas M. Lenz et al.
CYTOKINE (2007)
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Kenneth N. Agwuh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium
S Bratu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
A Montero et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
In vivo pharmacodynamics of a new oxazolidinone (linezolid)
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
